{"title":"WEIGHT","description":"\u003cp\u003eEngineered for those who approach body transformation as a science. Focusing on metabolic efficiency, appetite regulation, and adipose tissue modulation through next-generation compounds. Formulated to support energy expenditure, glycemic control, and sustainable fat oxidation, these products work in synergy with the body's natural hormonal and metabolic pathways.\u003c\/p\u003e","products":[{"product_id":"retlira-30-30mg-3ml-pen","title":"RETLIRA 30  30mg \/ 3ml Pen","description":"\u003ch2 data-end=\"172\" data-start=\"133\" data-section-id=\"1563v8x\"\u003eRETLIRA 30 Research Pen — 30mg \/ 3ml\u003c\/h2\u003e\n\u003cp data-end=\"339\" data-start=\"174\"\u003e\u003cstrong data-end=\"188\" data-start=\"174\"\u003eRETLIRA 30\u003c\/strong\u003e is a premium research-use peptide pen containing \u003cstrong data-end=\"285\" data-start=\"238\"\u003e30mg of Retatrutide in a 3ml pre-filled pen format\u003c\/strong\u003e, designed for accurate, convenient research handling.\u003c\/p\u003e\n\u003cp data-end=\"650\" data-start=\"341\"\u003eSourced from a specialist German laboratory, RETLIRA 30 is produced for customers who require a clean, professional presentation with reliable concentration and simple click-based dispensing. Each box includes one pre-filled research pen together with disposable needle tips for controlled laboratory use.\u003c\/p\u003e\n\u003cp data-end=\"989\" data-start=\"652\"\u003eReta is currently being researched for its potential activity across metabolic pathways, including GLP-1, GIP, and glucagon receptor signalling. It is not yet registered as an approved treatmen\u003cstrong data-end=\"850\" data-start=\"803\"\u003et\u003c\/strong\u003e, but early research has shown promising potential, making it one of the most talked-about compounds in the current research peptide space.\u003c\/p\u003e\n\u003cp data-is-only-node=\"\" data-is-last-node=\"\" data-end=\"1996\" data-start=\"1677\"\u003e \u003c\/p\u003e","brand":"Health-Tech","offers":[{"title":"Default Title","offer_id":48258932998369,"sku":"RETLIRA30","price":2400.0,"currency_code":"ZAR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0825\/1935\/9713\/files\/ChatGPTImageApr28_2026_01_37_00PM.png?v=1777446183"},{"product_id":"dex-pharma-tirz-max-pen-60mg-3ml","title":"Dex Pharma Tirz Max Pen - 60mg\/3mL","description":"\u003csection data-turn=\"assistant\" data-scroll-anchor=\"false\" data-testid=\"conversation-turn-4\" data-turn-id=\"request-WEB:ac7918e5-8b30-4840-8984-39958581a257-8\" dir=\"auto\" class=\"text-token-text-primary w-full focus:outline-none [--shadow-height:45px] has-data-writing-block:pointer-events-none has-data-writing-block:-mt-(--shadow-height) has-data-writing-block:pt-(--shadow-height) [\u0026amp;:has([data-writing-block])\u0026gt;*]:pointer-events-auto [content-visibility:auto] supports-[content-visibility:auto]:[contain-intrinsic-size:auto_100lvh] R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]\"\u003e\n\u003cdiv class=\"text-base my-auto mx-auto pb-10 [--thread-content-margin:var(--thread-content-margin-xs,calc(var(--spacing)*4))] @w-sm\/main:[--thread-content-margin:var(--thread-content-margin-sm,calc(var(--spacing)*6))] @w-lg\/main:[--thread-content-margin:var(--thread-content-margin-lg,calc(var(--spacing)*16))] px-(--thread-content-margin)\"\u003e\n\u003cdiv class=\"[--thread-content-max-width:40rem] @w-lg\/main:[--thread-content-max-width:48rem] mx-auto max-w-(--thread-content-max-width) flex-1 group\/turn-messages focus-visible:outline-hidden relative flex w-full min-w-0 flex-col agent-turn\"\u003e\n\u003cdiv class=\"flex max-w-full flex-col gap-4 grow\"\u003e\n\u003cdiv data-turn-start-message=\"true\" class=\"min-h-8 text-message relative flex w-full flex-col items-end gap-2 text-start break-words whitespace-normal outline-none keyboard-focused:focus-ring [.text-message+\u0026amp;]:mt-1\" data-message-model-slug=\"gpt-5-5-thinking\" dir=\"auto\" data-message-id=\"e5da8085-bbe0-40b3-8eae-c9d092c78704\" data-message-author-role=\"assistant\" tabindex=\"0\"\u003e\n\u003cdiv class=\"flex w-full flex-col gap-1 empty:hidden\"\u003e\n\u003cdiv class=\"markdown prose dark:prose-invert w-full wrap-break-word dark markdown-new-styling\"\u003e\n\u003csection data-turn=\"assistant\" data-scroll-anchor=\"false\" data-testid=\"conversation-turn-6\" data-turn-id=\"request-WEB:ac7918e5-8b30-4840-8984-39958581a257-9\" dir=\"auto\" class=\"text-token-text-primary w-full focus:outline-none [--shadow-height:45px] has-data-writing-block:pointer-events-none has-data-writing-block:-mt-(--shadow-height) has-data-writing-block:pt-(--shadow-height) [\u0026amp;:has([data-writing-block])\u0026gt;*]:pointer-events-auto [content-visibility:auto] supports-[content-visibility:auto]:[contain-intrinsic-size:auto_100lvh] R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]\"\u003e\n\u003cdiv class=\"text-base my-auto mx-auto pb-10 [--thread-content-margin:var(--thread-content-margin-xs,calc(var(--spacing)*4))] @w-sm\/main:[--thread-content-margin:var(--thread-content-margin-sm,calc(var(--spacing)*6))] @w-lg\/main:[--thread-content-margin:var(--thread-content-margin-lg,calc(var(--spacing)*16))] px-(--thread-content-margin)\"\u003e\n\u003cdiv class=\"[--thread-content-max-width:40rem] @w-lg\/main:[--thread-content-max-width:48rem] mx-auto max-w-(--thread-content-max-width) flex-1 group\/turn-messages focus-visible:outline-hidden relative flex w-full min-w-0 flex-col agent-turn\"\u003e\n\u003cdiv class=\"flex max-w-full flex-col gap-4 grow\"\u003e\n\u003cdiv data-turn-start-message=\"true\" class=\"min-h-8 text-message relative flex w-full flex-col items-end gap-2 text-start break-words whitespace-normal outline-none keyboard-focused:focus-ring [.text-message+\u0026amp;]:mt-1\" data-message-model-slug=\"gpt-5-5-thinking\" dir=\"auto\" data-message-id=\"2e355cf9-4288-47ab-9bbc-eb145ba1109a\" data-message-author-role=\"assistant\" tabindex=\"0\"\u003e\n\u003cdiv class=\"flex w-full flex-col gap-1 empty:hidden\"\u003e\n\u003cdiv class=\"markdown prose dark:prose-invert w-full wrap-break-word dark markdown-new-styling\"\u003e\n\u003cp data-end=\"222\" data-start=\"47\"\u003e\u003cstrong data-end=\"68\" data-start=\"47\"\u003eTirz Max 60mg\/3mL\u003c\/strong\u003e is a premium, high-strength tirzepatide research pen, sourced from Germany and produced to a high-purity standard for advanced research applications.\u003c\/p\u003e\n\u003cp data-end=\"512\" data-start=\"224\"\u003eWith a total content of \u003cstrong data-end=\"263\" data-start=\"248\"\u003e60mg in 3mL\u003c\/strong\u003e, Tirz Max offers a much higher milligram amount than many lower-strength tirzepatide pens commonly being sold. This makes it a practical option for customers looking for a larger-capacity research pen with more flexibility and longer use potential.\u003c\/p\u003e\n\u003cp data-end=\"728\" data-start=\"514\"\u003eTirzepatide is a dual-action compound currently being studied for its activity on the GIP and GLP-1 pathways, which are linked to appetite, metabolic response, glucose regulation, and body-composition research.\u003c\/p\u003e\n\u003ch3 data-end=\"746\" data-start=\"730\" data-section-id=\"1iz91iu\"\u003eKey Features\u003c\/h3\u003e\n\u003cp data-end=\"866\" data-start=\"748\"\u003e\u003cstrong data-end=\"782\" data-start=\"748\"\u003eHigh-strength 60mg formulation\u003c\/strong\u003e\u003cbr data-end=\"785\" data-start=\"782\"\u003eHigher total milligram content than many standard tirzepatide pens on the market.\u003c\/p\u003e\n\u003cp data-end=\"976\" data-start=\"868\"\u003e\u003cstrong data-end=\"892\" data-start=\"868\"\u003eSourced from Germany\u003c\/strong\u003e\u003cbr data-end=\"895\" data-start=\"892\"\u003eSupplied from a German laboratory source with a focus on quality and consistency.\u003c\/p\u003e\n\u003cp data-end=\"1069\" data-start=\"978\"\u003e\u003cstrong data-end=\"1005\" data-start=\"978\"\u003eHigh-purity Tirzepatide\u003c\/strong\u003e\u003cbr data-end=\"1008\" data-start=\"1005\"\u003eProduced to a high-purity standard for reliable research use.\u003c\/p\u003e\n\u003cp data-end=\"1165\" data-start=\"1071\"\u003e\u003cstrong data-end=\"1100\" data-start=\"1071\"\u003eConvenient 3mL pen format\u003c\/strong\u003e\u003cbr data-end=\"1103\" data-start=\"1100\"\u003eEasy-to-handle pre-filled style pen with included needle tips.\u003c\/p\u003e\n\u003cp data-end=\"1282\" data-start=\"1167\"\u003e \u003c\/p\u003e\n\u003ch3 data-end=\"1304\" data-start=\"1284\" data-section-id=\"8yq2t6\"\u003eImportant Notice\u003c\/h3\u003e\n\u003cp data-is-only-node=\"\" data-is-last-node=\"\" data-end=\"1666\" data-start=\"1306\"\u003eThis product is supplied strictly for \u003cstrong data-end=\"1365\" data-start=\"1344\"\u003eresearch use only\u003c\/strong\u003e. It is not sold as an approved treatment, medicine, or substitute for professional medical advice. Tirzepatide is currently being researched and has shown promising potential in metabolic and body-composition studies, but this product is not intended to diagnose, treat, cure, or prevent any disease.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"z-0 flex min-h-[46px] justify-start\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv class=\"mt-3 w-full empty:hidden\"\u003e\n\u003cdiv class=\"text-center\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"z-0 flex min-h-[46px] justify-start\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv class=\"mt-3 w-full empty:hidden\"\u003e\n\u003cdiv class=\"text-center\"\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cem\u003e\u003cstrong\u003eUSAGE\u0026amp;DOSAGE\u003c\/strong\u003e\u003c\/em\u003e\u003c\/span\u003e\u003c\/div\u003e\n\u003cdiv class=\"text-center\"\u003e\n\u003cspan style=\"text-decoration: underline;\"\u003e\u003cem\u003e\u003cstrong\u003e\u003c\/strong\u003e\u003c\/em\u003e\u003c\/span\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"text-center\"\u003e\n\u003ch2 data-end=\"395\" data-start=\"358\" data-section-id=\"o8oj3s\"\u003eGeneral Tirzepatide Dose Reference\u003c\/h2\u003e\n\u003cp data-end=\"839\" data-start=\"397\"\u003eTirzepatide is commonly introduced gradually to improve tolerability. In approved prescription products, the standard adult starting dose is \u003cstrong data-end=\"571\" data-start=\"538\"\u003e2.5mg once weekly for 4 weeks\u003c\/strong\u003e, followed by \u003cstrong data-end=\"604\" data-start=\"585\"\u003e5mg once weekly\u003c\/strong\u003e. If further escalation is appropriate, doses are usually increased in \u003cstrong data-end=\"690\" data-start=\"675\"\u003e2.5mg steps\u003c\/strong\u003e after at least \u003cstrong data-end=\"717\" data-start=\"706\"\u003e4 weeks\u003c\/strong\u003e on the current dose. The commonly referenced adult maximum is \u003cstrong data-end=\"800\" data-start=\"780\"\u003e15mg once weekly\u003c\/strong\u003e. \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3 data-end=\"873\" data-start=\"841\" data-section-id=\"umy4s2\"\u003eTypical Escalation Reference\u003c\/h3\u003e\n\u003cdiv class=\"TyagGW_tableContainer\"\u003e\n\u003cdiv class=\"group TyagGW_tableWrapper flex flex-col-reverse w-fit\" tabindex=\"-1\"\u003e\n\u003ctable class=\"w-fit min-w-(--thread-content-width)\" data-end=\"1137\" data-start=\"875\"\u003e\n\u003cthead data-end=\"909\" data-start=\"875\"\u003e\n\u003ctr data-end=\"909\" data-start=\"875\"\u003e\n\u003cth class=\"\" data-col-size=\"sm\" data-end=\"883\" data-start=\"875\"\u003eStage\u003c\/th\u003e\n\u003cth class=\"\" data-col-size=\"sm\" data-end=\"909\" data-start=\"883\"\u003eGeneral reference dose\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-end=\"1137\" data-start=\"921\"\u003e\n\u003ctr data-end=\"954\" data-start=\"921\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"933\" data-start=\"921\"\u003eWeeks 1–4\u003c\/td\u003e\n\u003ctd data-end=\"954\" data-start=\"933\" data-col-size=\"sm\"\u003e2.5mg once weekly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"986\" data-start=\"955\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"967\" data-start=\"955\"\u003eWeeks 5–8\u003c\/td\u003e\n\u003ctd data-end=\"986\" data-start=\"967\" data-col-size=\"sm\"\u003e5mg once weekly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"1021\" data-start=\"987\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"1000\" data-start=\"987\"\u003eWeeks 9–12\u003c\/td\u003e\n\u003ctd data-end=\"1021\" data-start=\"1000\" data-col-size=\"sm\"\u003e7.5mg once weekly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"1056\" data-start=\"1022\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"1036\" data-start=\"1022\"\u003eWeeks 13–16\u003c\/td\u003e\n\u003ctd data-end=\"1056\" data-start=\"1036\" data-col-size=\"sm\"\u003e10mg once weekly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"1093\" data-start=\"1057\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"1071\" data-start=\"1057\"\u003eWeeks 17–20\u003c\/td\u003e\n\u003ctd data-end=\"1093\" data-start=\"1071\" data-col-size=\"sm\"\u003e12.5mg once weekly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"1137\" data-start=\"1094\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"1111\" data-start=\"1094\"\u003eWeek 21 onward\u003c\/td\u003e\n\u003ctd data-end=\"1137\" data-start=\"1111\" data-col-size=\"sm\"\u003eUp to 15mg once weekly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cp data-end=\"1519\" data-start=\"1139\"\u003eA newcomer would generally start at the \u003cstrong data-end=\"1208\" data-start=\"1179\"\u003elowest introduction level\u003c\/strong\u003e, not at a high dose, because nausea, appetite suppression, reflux, constipation, diarrhoea, fatigue, and dehydration are more likely when increasing too quickly. Official prescribing information specifically uses gradual escalation to reduce gastrointestinal side effects. \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3 data-end=\"1551\" data-start=\"1521\" data-section-id=\"vypko5\"\u003eBest-Practice Use Guidance\u003c\/h3\u003e\n\u003cp data-end=\"1850\" data-start=\"1553\"\u003eTirzepatide is normally taken \u003cstrong data-end=\"1598\" data-start=\"1583\"\u003eonce weekly\u003c\/strong\u003e, on the same day each week. It is administered by \u003cstrong data-end=\"1675\" data-start=\"1649\"\u003esubcutaneous injection\u003c\/strong\u003e, commonly into the abdomen, thigh, or upper arm, with injection sites rotated each time. It can generally be taken with or without food. \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp data-end=\"2071\" data-start=\"1852\"\u003eFor best tolerance, users are commonly advised to keep meals smaller, avoid very fatty or heavy meals around dosing day, drink enough fluids, prioritise protein, and avoid escalating while side effects are still strong.\u003c\/p\u003e\n\u003cp data-end=\"2071\" data-start=\"1852\"\u003e \u003c\/p\u003e\n\u003cp data-end=\"2071\" data-start=\"1852\"\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cem\u003e\u003cstrong\u003eFAQ \u003c\/strong\u003e\u003c\/em\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003csection data-turn=\"assistant\" data-scroll-anchor=\"false\" data-testid=\"conversation-turn-10\" data-turn-id=\"request-WEB:ac7918e5-8b30-4840-8984-39958581a257-11\" dir=\"auto\" class=\"text-token-text-primary w-full focus:outline-none [--shadow-height:45px] has-data-writing-block:pointer-events-none has-data-writing-block:-mt-(--shadow-height) has-data-writing-block:pt-(--shadow-height) [\u0026amp;:has([data-writing-block])\u0026gt;*]:pointer-events-auto [content-visibility:auto] supports-[content-visibility:auto]:[contain-intrinsic-size:auto_100lvh] R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]\"\u003e\n\u003cdiv class=\"text-base my-auto mx-auto pb-10 [--thread-content-margin:var(--thread-content-margin-xs,calc(var(--spacing)*4))] @w-sm\/main:[--thread-content-margin:var(--thread-content-margin-sm,calc(var(--spacing)*6))] @w-lg\/main:[--thread-content-margin:var(--thread-content-margin-lg,calc(var(--spacing)*16))] px-(--thread-content-margin)\"\u003e\n\u003cdiv class=\"[--thread-content-max-width:40rem] @w-lg\/main:[--thread-content-max-width:48rem] mx-auto max-w-(--thread-content-max-width) flex-1 group\/turn-messages focus-visible:outline-hidden relative flex w-full min-w-0 flex-col agent-turn\"\u003e\n\u003cdiv class=\"flex max-w-full flex-col gap-4 grow\"\u003e\n\u003cdiv data-turn-start-message=\"true\" class=\"min-h-8 text-message relative flex w-full flex-col items-end gap-2 text-start break-words whitespace-normal outline-none keyboard-focused:focus-ring [.text-message+\u0026amp;]:mt-1\" data-message-model-slug=\"gpt-5-5-thinking\" dir=\"auto\" data-message-id=\"14ba3a4d-4a22-478e-96de-74ccbfba04b3\" data-message-author-role=\"assistant\" tabindex=\"0\"\u003e\n\u003cdiv class=\"flex w-full flex-col gap-1 empty:hidden\"\u003e\n\u003cdiv class=\"markdown prose dark:prose-invert w-full wrap-break-word dark markdown-new-styling\"\u003e\n\u003ch2 data-end=\"216\" data-start=\"197\" data-section-id=\"1q49hct\"\u003eTirzepatide FAQs\u003c\/h2\u003e\n\u003ch3 data-end=\"245\" data-start=\"218\" data-section-id=\"13vluuj\"\u003e1. What is tirzepatide?\u003c\/h3\u003e\n\u003cp data-end=\"608\" data-start=\"247\"\u003eTirzepatide is a peptide-based compound that acts on both \u003cstrong data-end=\"340\" data-start=\"305\"\u003eGIP and GLP-1 receptor pathways\u003c\/strong\u003e. These pathways are involved in appetite signalling, glucose regulation, insulin response, and metabolic research. Prescription tirzepatide products are marketed internationally under brands such as \u003cstrong data-end=\"552\" data-start=\"540\"\u003eMounjaro\u003c\/strong\u003e and \u003cstrong data-end=\"569\" data-start=\"557\"\u003eZepbound\u003c\/strong\u003e. \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3 data-end=\"668\" data-start=\"610\" data-section-id=\"1cvjnpl\"\u003e2. Is this the same active compound found in Mounjaro?\u003c\/h3\u003e\n\u003cp data-end=\"998\" data-start=\"670\"\u003eThe active compound is \u003cstrong data-end=\"708\" data-start=\"693\"\u003etirzepatide\u003c\/strong\u003e, the same molecule used in approved prescription products such as Mounjaro and Zepbound. However, this product is supplied as a \u003cstrong data-end=\"861\" data-start=\"837\"\u003eresearch-use product\u003c\/strong\u003e and is not sold as an approved medicine, treatment, or substitute for a doctor-prescribed product. \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3 data-end=\"1063\" data-start=\"1000\" data-section-id=\"cj512u\"\u003e3. What makes Tirz Max 60mg different from many other pens?\u003c\/h3\u003e\n\u003cp data-end=\"1345\" data-start=\"1065\"\u003eTirz Max contains \u003cstrong data-end=\"1098\" data-start=\"1083\"\u003e60mg in 3mL\u003c\/strong\u003e, which is a higher total milligram amount than many lower-strength tirzepatide pens commonly sold online. This gives a larger total amount of tirzepatide in one pen, but users should not assume that “higher mg” means they should use more at once.\u003c\/p\u003e\n\u003ch3 data-end=\"1395\" data-start=\"1347\" data-section-id=\"1mh4s22\"\u003e4. What is tirzepatide being researched for?\u003c\/h3\u003e\n\u003cp data-end=\"1681\" data-start=\"1397\"\u003eTirzepatide is being researched and used in regulated medical settings for \u003cstrong data-end=\"1568\" data-start=\"1472\"\u003etype 2 diabetes, weight-management, appetite control, glucose handling, and metabolic health\u003c\/strong\u003e. In approved medical use, it is prescribed under professional supervision. \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3 data-end=\"1729\" data-start=\"1683\" data-section-id=\"92gfx5\"\u003e5. Is tirzepatide approved as a treatment?\u003c\/h3\u003e\n\u003cp data-end=\"2077\" data-start=\"1731\"\u003eYes, tirzepatide is approved in some countries as a prescription medicine under regulated brand names. However, approval depends on the country, indication, and product registration. This specific pen should be presented as \u003cstrong data-end=\"1976\" data-start=\"1955\"\u003eresearch use only\u003c\/strong\u003e unless it is formally registered as a medicine in your market. \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3 data-end=\"2149\" data-start=\"2079\" data-section-id=\"mo2c6y\"\u003e6. How often is tirzepatide usually taken in approved medical use?\u003c\/h3\u003e\n\u003cp data-end=\"2414\" data-start=\"2151\"\u003eIn approved prescription use, tirzepatide is generally administered \u003cstrong data-end=\"2234\" data-start=\"2219\"\u003eonce weekly\u003c\/strong\u003e by subcutaneous injection. This is a general reference from approved product information, not a custom dosing instruction for a research pen. \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3 data-end=\"2496\" data-start=\"2416\" data-section-id=\"11uyqi8\"\u003e7. What is the usual beginner starting point in official medical references?\u003c\/h3\u003e\n\u003cp data-end=\"2832\" data-start=\"2498\"\u003eOfficial prescribing information commonly starts tirzepatide at a low introductory dose and then increases gradually. This slow escalation is used to improve tolerability, especially stomach-related side effects. Any actual dosing decision should be made with a qualified healthcare professional. \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3 data-end=\"2873\" data-start=\"2834\" data-section-id=\"1ipxy72\"\u003e8. Why do people usually start low?\u003c\/h3\u003e\n\u003cp data-end=\"3194\" data-start=\"2875\"\u003eTirzepatide can cause nausea, reflux, appetite suppression, constipation, diarrhoea, stomach discomfort, fatigue, and dehydration, especially if increased too quickly. Starting low and increasing slowly is the standard approach in approved medical protocols to reduce side effects. \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3 data-end=\"3242\" data-start=\"3196\" data-section-id=\"ci1av0\"\u003e9. Where is tirzepatide normally injected?\u003c\/h3\u003e\n\u003cp data-end=\"3507\" data-start=\"3244\"\u003ePrescription tirzepatide is normally injected \u003cstrong data-end=\"3308\" data-start=\"3290\"\u003esubcutaneously\u003c\/strong\u003e, meaning into the fatty layer under the skin. Common injection areas include the \u003cstrong data-end=\"3422\" data-start=\"3390\"\u003eabdomen, thigh, or upper arm\u003c\/strong\u003e, with rotation of injection sites recommended. \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3 data-end=\"3546\" data-start=\"3509\" data-section-id=\"1xdv07s\"\u003e10. What are common side effects?\u003c\/h3\u003e\n\u003cp data-end=\"3823\" data-start=\"3548\"\u003eCommonly reported side effects include \u003cstrong data-end=\"3700\" data-start=\"3587\"\u003enausea, vomiting, diarrhoea, constipation, burping, reflux, stomach discomfort, reduced appetite, and fatigue\u003c\/strong\u003e. Many users report that side effects are strongest when starting or increasing dose. \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3 data-end=\"3884\" data-start=\"3825\" data-section-id=\"11irk2g\"\u003e11. What do users commonly say helps with side effects?\u003c\/h3\u003e\n\u003cp data-end=\"4235\" data-start=\"3886\"\u003eAcross patient forums and social discussions, common practical tips include eating smaller meals, avoiding greasy or very heavy foods, drinking more water, keeping protein intake steady, adding fibre, and not skipping meals completely. These are anecdotal lifestyle tips and should not replace medical guidance. \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3 data-end=\"4301\" data-start=\"4237\" data-section-id=\"ehxnet\"\u003e12. What should a newcomer know before starting tirzepatide?\u003c\/h3\u003e\n\u003cp data-end=\"4745\" data-start=\"4303\"\u003eA newcomer should understand that tirzepatide can be powerful, appetite reduction can be strong, and side effects can happen. They should avoid rushing dose increases, stay hydrated, eat enough protein, and seek medical advice if they have diabetes, use insulin or sulfonylureas, have kidney issues, gallbladder problems, pancreatitis history, severe stomach problems, or are pregnant or breastfeeding. \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3 data-end=\"4809\" data-start=\"4747\" data-section-id=\"8yh0jf\"\u003e13. What serious warnings are associated with tirzepatide?\u003c\/h3\u003e\n\u003cp data-end=\"5228\" data-start=\"4811\"\u003eOfficial prescribing information includes warnings around thyroid C-cell tumour risk observed in animal studies, pancreatitis, gallbladder disease, kidney injury related to dehydration, low blood sugar when combined with certain diabetes medicines, severe gastrointestinal reactions, allergic reactions, and possible worsening of diabetic retinopathy in some diabetic patients. \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3 data-end=\"5278\" data-start=\"5230\" data-section-id=\"1mvdcz0\"\u003e14. What happens if a weekly dose is missed?\u003c\/h3\u003e\n\u003cp data-end=\"5581\" data-start=\"5280\"\u003eIn official patient guidance, if a dose is missed and it is within a certain time window, it may be taken when remembered; if too much time has passed, the missed dose is skipped and the normal schedule resumed. It is important not to double-dose to “catch up.” \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3 data-end=\"5629\" data-start=\"5583\" data-section-id=\"j2hvh3\"\u003e15. Is this product suitable for everyone?\u003c\/h3\u003e\n\u003cp data-end=\"6234\" data-start=\"5631\"\u003eNo. Tirzepatide is not suitable for everyone. It should be avoided or used only with proper medical guidance in people with certain medical histories or those taking specific medications. For your Shopify page, the safest wording is: \u003cstrong data-end=\"5992\" data-start=\"5865\"\u003e“This product is supplied for research purposes only and is not intended to diagnose, treat, cure, or prevent any disease.”\u003c\/strong\u003e Regulatory authorities have warned some online sellers about marketing “research use only” GLP-1 products for human consumption, so avoid making direct treatment claims or personalised dosing promises. \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"z-0 flex min-h-[46px] justify-start\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv class=\"mt-3 w-full empty:hidden\"\u003e\n\u003cdiv class=\"text-center\"\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cem\u003e\u003cstrong\u003eRESEARCH \u0026amp; RECOMMENDATIONS\u003c\/strong\u003e\u003c\/em\u003e\u003c\/span\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cp data-end=\"2071\" data-start=\"1852\"\u003e \u003c\/p\u003e\n\u003ch2 data-end=\"53\" data-start=\"0\" data-section-id=\"m0bbnn\"\u003eHealthy Eating \u0026amp; Lifestyle While Using Tirzepatide\u003c\/h2\u003e\n\u003cp data-end=\"667\" data-start=\"55\"\u003eTirzepatide works best when paired with a proper lifestyle plan, not treated as a replacement for healthy habits. Because appetite may drop sharply, users should focus on \u003cstrong data-end=\"251\" data-start=\"226\"\u003equality over quantity\u003c\/strong\u003e: smaller meals, high-protein foods, vegetables, fruit, whole grains, healthy fats, and plenty of water. The best eating approach is usually a \u003cstrong data-end=\"451\" data-start=\"394\"\u003ehigh-protein, lower-sugar, moderate-carbohydrate diet\u003c\/strong\u003e, with meals kept light and clean to reduce nausea or reflux. Very greasy, very sweet, or overly large meals can make stomach side effects worse, so many people do better with smaller portions spread through the day.\u003c\/p\u003e\n\u003cp data-end=\"1312\" data-start=\"669\"\u003eExercise should be introduced gradually and consistently. A good starting point is \u003cstrong data-end=\"769\" data-start=\"752\"\u003edaily walking\u003c\/strong\u003e, then adding light resistance training 2–4 times per week to help preserve muscle while weight is coming down. This is important because fast weight loss can include muscle loss if protein intake and strength training are too low. The ideal lifestyle goal is not just to lose weight, but to build a routine that can be maintained long term: better food choices, regular movement, enough sleep, hydration, and reduced alcohol\/sugary snacks. Tirzepatide should be viewed as a support tool alongside lifestyle change, not a stand-alone solution.\u003c\/p\u003e\n\u003ch2 data-end=\"1349\" data-start=\"1314\" data-section-id=\"xoxky3\"\u003eRecent Tirzepatide Trial Results\u003c\/h2\u003e\n\u003cp data-end=\"1863\" data-start=\"1351\"\u003e\u003cstrong data-end=\"1393\" data-start=\"1351\"\u003eSURMOUNT-5: Tirzepatide vs Semaglutide\u003c\/strong\u003e\u003cbr data-end=\"1396\" data-start=\"1393\"\u003eIn this direct head-to-head obesity trial, tirzepatide produced greater average weight reduction than semaglutide over 72 weeks. Participants using tirzepatide lost about \u003cstrong data-end=\"1591\" data-start=\"1567\"\u003e20.2% of body weight\u003c\/strong\u003e, compared with about \u003cstrong data-end=\"1622\" data-start=\"1613\"\u003e13.7%\u003c\/strong\u003e for semaglutide, and also saw stronger waist-size reduction. This made tirzepatide one of the strongest published results in a direct comparison against semaglutide for weight loss.\u003cbr data-end=\"1807\" data-start=\"1804\"\u003eLink: \u003ca href=\"https:\/\/www.nejm.org\/doi\/abs\/10.1056\/NEJMoa2416394?utm_source=chatgpt.com\" class=\"decorated-link\" rel=\"noopener\" data-end=\"1863\" data-start=\"1813\"\u003ehttps:\/\/www.nejm.org\/doi\/abs\/10.1056\/NEJMoa2416394\u003cspan class=\"ms-0.5 inline-block align-middle leading-none\" aria-hidden=\"true\"\u003e\u003csvg class=\"block h-[0.75em] w-[0.75em] stroke-current stroke-[0.75]\" data-rtl-flip=\"\" aria-hidden=\"true\" height=\"20\" width=\"20\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"\u003e\u003cuse fill=\"currentColor\" href=\"\/cdn\/assets\/sprites-core-00d8790d.svg#304883\"\u003e\u003c\/use\u003e\u003c\/svg\u003e\u003c\/span\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp data-end=\"2340\" data-start=\"1865\"\u003e\u003cstrong data-end=\"1919\" data-start=\"1865\"\u003eSURMOUNT-1: Long-Term Obesity and Prediabetes Data\u003c\/strong\u003e\u003cbr data-end=\"1922\" data-start=\"1919\"\u003eLonger-term SURMOUNT-1 findings showed that tirzepatide produced sustained weight reduction over around three years and helped delay progression from prediabetes to type 2 diabetes in people with obesity. This is important because it suggests tirzepatide may support not only weight reduction, but also longer-term metabolic improvement in high-risk patients.\u003cbr data-end=\"2284\" data-start=\"2281\"\u003eLink: \u003ca href=\"https:\/\/www.nejm.org\/doi\/abs\/10.1056\/NEJMoa2410819?utm_source=chatgpt.com\" class=\"decorated-link\" rel=\"noopener\" data-end=\"2340\" data-start=\"2290\"\u003ehttps:\/\/www.nejm.org\/doi\/abs\/10.1056\/NEJMoa2410819\u003cspan class=\"ms-0.5 inline-block align-middle leading-none\" aria-hidden=\"true\"\u003e\u003csvg class=\"block h-[0.75em] w-[0.75em] stroke-current stroke-[0.75]\" data-rtl-flip=\"\" aria-hidden=\"true\" height=\"20\" width=\"20\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"\u003e\u003cuse fill=\"currentColor\" href=\"\/cdn\/assets\/sprites-core-00d8790d.svg#304883\"\u003e\u003c\/use\u003e\u003c\/svg\u003e\u003c\/span\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp data-end=\"2826\" data-start=\"2342\"\u003e\u003cstrong data-end=\"2412\" data-start=\"2342\"\u003eSUMMIT: Heart Failure With Preserved Ejection Fraction and Obesity\u003c\/strong\u003e\u003cbr data-end=\"2415\" data-start=\"2412\"\u003eIn patients with obesity and heart failure with preserved ejection fraction, tirzepatide reduced the risk of cardiovascular death or worsening heart-failure events compared with placebo. Patients also showed improvements in health status and physical limitations, suggesting potential benefits beyond weight loss in obesity-related heart-health conditions.\u003cbr data-end=\"2774\" data-start=\"2771\"\u003eLink: \u003ca href=\"https:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa2410027?utm_source=chatgpt.com\" class=\"decorated-link\" rel=\"noopener\" data-end=\"2826\" data-start=\"2780\"\u003ehttps:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa2410027\u003cspan class=\"ms-0.5 inline-block align-middle leading-none\" aria-hidden=\"true\"\u003e\u003csvg class=\"block h-[0.75em] w-[0.75em] stroke-current stroke-[0.75]\" data-rtl-flip=\"\" aria-hidden=\"true\" height=\"20\" width=\"20\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"\u003e\u003cuse fill=\"currentColor\" href=\"\/cdn\/assets\/sprites-core-00d8790d.svg#304883\"\u003e\u003c\/use\u003e\u003c\/svg\u003e\u003c\/span\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp data-end=\"3335\" data-start=\"2828\"\u003e\u003cstrong data-end=\"2881\" data-start=\"2828\"\u003eSURMOUNT-OSA: Obstructive Sleep Apnea and Obesity\u003c\/strong\u003e\u003cbr data-end=\"2884\" data-start=\"2881\"\u003eIn people with obesity and moderate-to-severe obstructive sleep apnea, tirzepatide significantly reduced sleep-apnea severity, including improvements in apnea-hypopnea index, body weight, oxygen-related burden, inflammation markers, blood pressure, and sleep-related quality-of-life measures. These results suggest tirzepatide may have meaningful benefits in obesity-related sleep apnea research.\u003cbr data-end=\"3283\" data-start=\"3280\"\u003eLink: \u003ca href=\"https:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa2404881?utm_source=chatgpt.com\" class=\"decorated-link\" rel=\"noopener\" data-end=\"3335\" data-start=\"3289\"\u003ehttps:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa2404881\u003cspan class=\"ms-0.5 inline-block align-middle leading-none\" aria-hidden=\"true\"\u003e\u003csvg class=\"block h-[0.75em] w-[0.75em] stroke-current stroke-[0.75]\" data-rtl-flip=\"\" aria-hidden=\"true\" height=\"20\" width=\"20\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"\u003e\u003cuse fill=\"currentColor\" href=\"\/cdn\/assets\/sprites-core-00d8790d.svg#304883\"\u003e\u003c\/use\u003e\u003c\/svg\u003e\u003c\/span\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp data-end=\"3787\" data-start=\"3337\"\u003e\u003cstrong data-end=\"3381\" data-start=\"3337\"\u003eSYNERGY-NASH \/ MASH Liver-Fibrosis Trial\u003c\/strong\u003e\u003cbr data-end=\"3384\" data-start=\"3381\"\u003eIn people with MASH, previously called NASH, and moderate-to-severe liver fibrosis, tirzepatide was more effective than placebo at achieving MASH resolution without worsening fibrosis after 52 weeks. These findings are promising because they suggest tirzepatide may have potential in obesity- and metabolism-linked fatty liver disease research.\u003cbr data-end=\"3731\" data-start=\"3728\"\u003eLink: \u003ca href=\"https:\/\/www.nejm.org\/doi\/abs\/10.1056\/NEJMoa2401943?utm_source=chatgpt.com\" class=\"decorated-link\" rel=\"noopener\" data-end=\"3787\" data-start=\"3737\"\u003ehttps:\/\/www.nejm.org\/doi\/abs\/10.1056\/NEJMoa2401943\u003cspan class=\"ms-0.5 inline-block align-middle leading-none\" aria-hidden=\"true\"\u003e\u003csvg class=\"block h-[0.75em] w-[0.75em] stroke-current stroke-[0.75]\" data-rtl-flip=\"\" aria-hidden=\"true\" height=\"20\" width=\"20\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"\u003e\u003cuse fill=\"currentColor\" href=\"\/cdn\/assets\/sprites-core-00d8790d.svg#304883\"\u003e\u003c\/use\u003e\u003c\/svg\u003e\u003c\/span\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp data-is-only-node=\"\" data-is-last-node=\"\" data-end=\"4074\" data-start=\"3789\"\u003e\u003cstrong data-end=\"3814\" data-start=\"3789\"\u003eDisclaimer:\u003c\/strong\u003e\u003cbr data-end=\"3817\" data-start=\"3814\"\u003eTirzepatide is currently being researched and has shown promising potential in published clinical studies. This product is supplied for research purposes only and is not sold as an approved treatment, medicine, or substitute for professional medical advice.\u003c\/p\u003e\n\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e","brand":"Xander","offers":[{"title":"Default Title","offer_id":48259054469345,"sku":"DEXTIRZMAX60","price":2900.0,"currency_code":"ZAR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0825\/1935\/9713\/files\/ChatGPTImageApr29_2026_09_52_25AM.png?v=1777450804"},{"product_id":"dex-pharma-reta-max-50mg-3ml-pen","title":"Dex Pharma Reta Max 50mg\/3mL Pen","description":"\u003cp\u003e\u003cspan\u003eThe 50mg\/3ml Retatrutide (GLP-3RT) pen is a next-generation metabolic optimizer that targets three different receptors: GLP-1, GIP, and Glucagon. This \"triple agonist\" approach makes it exceptionally powerful for weight management and metabolic health.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003eRetatrutide is often called a \"3-Way Agonist\" because it targets three metabolic pathways simultaneously, making it more potent than Semaglutide or Tirzepatide. By activating GLP-1, GIP, and Glucagon receptors, it addresses weight loss through appetite suppression and increased energy expenditure.\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eDetailed Mechanism\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eGLP-1 \u0026amp; GIP:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eThese work together to slow digestion, suppress appetite, and improve how your body handles insulin.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGlucagon Power:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eThis third receptor is the \"secret sauce\"—it increases your resting metabolic rate and targets fat burning in the liver.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTriple Synergy:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eCombining these three allows for significant weight loss with potentially better metabolic protection than single or dual-agonist peptides.\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Health Tech","offers":[{"title":"Default Title","offer_id":48268204376289,"sku":null,"price":2900.0,"currency_code":"ZAR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0825\/1935\/9713\/files\/DexReta1.png?v=1777805164"},{"product_id":"mots-c-2ml-multi-dose-pen-200-clicks","title":"Noventra MOTS-c – 2ml Multi Dose Pen (200 Clicks)","description":"\u003cp\u003eNoventra MOTS-c is a mitochondrial-derived peptide formulated to support cellular energy production, metabolism, fat utilization, and overall metabolic performance. This advanced peptide is commonly explored for its potential role in improving endurance, insulin sensitivity, and energy efficiency at the cellular level.\u003c\/p\u003e\n\u003cp\u003eDesigned for individuals seeking enhanced fat metabolism and performance support, MOTS-c may assist with stubborn fat reduction while helping preserve lean muscle mass. The formulation is also associated with improved recovery, increased vitality, and enhanced focus through optimized mitochondrial activity.\u003c\/p\u003e\n\u003cp\u003eDelivered in a convenient \u003cstrong data-start=\"791\" data-end=\"829\"\u003e2ml Multi Dose Pen with 200 clicks\u003c\/strong\u003e, MOTS-c offers precise dosing and easy subcutaneous administration. The peptide is designed for consistent peptide delivery and is commonly used in metabolic optimization, recovery enhancement, and performance-focused protocols.\u003c\/p\u003e","brand":"Health Tech","offers":[{"title":"Default Title","offer_id":48375621681377,"sku":null,"price":1090.0,"currency_code":"ZAR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0825\/1935\/9713\/files\/Noventra_Pharma_MOTS-c_multi-dose_pen.png?v=1778962943"},{"product_id":"semaglutide-2ml-multi-dose-pen-200-clicks","title":"Noventra Semaglutide – 2ml Multi Dose Pen (200 Clicks)","description":"\u003cp\u003eNoventra Semaglutide is a GLP-1 receptor agonist peptide formulated to support effective weight management, appetite control, and metabolic health. This advanced peptide is widely researched for its ability to help regulate hunger signals, improve satiety, and support sustainable body composition goals.\u003c\/p\u003e\n\u003cp\u003eThe formulation is designed to assist with reducing calorie intake by promoting feelings of fullness while supporting blood sugar regulation and metabolic efficiency. Semaglutide is commonly used in structured weight management protocols alongside nutrition and lifestyle modifications.\u003c\/p\u003e\n\u003cp\u003eDelivered in a convenient \u003cstrong data-start=\"758\" data-end=\"796\"\u003e2ml Multi Dose Pen with 200 clicks\u003c\/strong\u003e, the product allows for precise and consistent weekly dosing through subcutaneous administration. The easy-to-use pen system supports gradual dosage escalation protocols for optimized tolerance and long-term consistency.\u003c\/p\u003e","brand":"Health Tech","offers":[{"title":"Default Title","offer_id":48376685396193,"sku":null,"price":1090.0,"currency_code":"ZAR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0825\/1935\/9713\/files\/semaglutide_peptide_pen.png?v=1779005539"},{"product_id":"retrexa-hybrid-44mg-2-4ml-multi-dose-pen-240-clicks","title":"Noventra Retrexa Hybrid 44mg – 2.4ml Multi Dose Pen (240 Clicks)","description":"\u003cp\u003eNoventra Retrexa Hybrid is an advanced metabolic peptide blend combining \u003cstrong data-start=\"185\" data-end=\"225\"\u003eRetatrutide 32mg and Naltrexone 12mg\u003c\/strong\u003e in a single multi-dose pen formulation. Designed to support weight management, appetite regulation, and metabolic enhancement, this hybrid peptide system targets multiple pathways involved in fat metabolism and energy balance.\u003c\/p\u003e\n\u003cp\u003eThe formulation is designed to activate \u003cstrong data-start=\"512\" data-end=\"550\"\u003eGLP-1, GIP, and glucagon receptors\u003c\/strong\u003e to support appetite suppression, reduced cravings, improved insulin sensitivity, and sustained energy levels. The addition of Naltrexone is intended to help support craving control and emotional eating management while enhancing overall metabolic support.\u003c\/p\u003e\n\u003cp\u003eDelivered through a convenient \u003cstrong data-start=\"857\" data-end=\"897\"\u003e2.4ml Multi Dose Pen with 240 clicks\u003c\/strong\u003e, Retrexa Hybrid allows for precise and progressive weekly dosing. The formulation is designed for individuals seeking advanced weight management support, improved metabolic efficiency, and enhanced body composition optimization.\u003c\/p\u003e","brand":"Health Tech","offers":[{"title":"Default Title","offer_id":48376691556577,"sku":null,"price":2750.0,"currency_code":"ZAR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0825\/1935\/9713\/files\/Retrexa_Hybrid_multi-dose_peptide_pen.png?v=1779006495"},{"product_id":"retatrutide-64mg-2ml-multi-dose-pen-200-clicks","title":"Noventra Retatrutide 64mg – 2ml Multi Dose Pen (200 Clicks)","description":"\u003cp data-start=\"116\" data-end=\"423\"\u003eNoventra Retatrutide is an advanced triple-action peptide formulation designed to support weight management, appetite control, and metabolic optimization. This next-generation peptide activates \u003cstrong data-start=\"301\" data-end=\"339\"\u003eGLP-1, GIP, and glucagon receptors\u003c\/strong\u003e to help regulate hunger, energy expenditure, and glucose metabolism simultaneously.\u003c\/p\u003e\n\u003cp data-start=\"116\" data-end=\"423\"\u003eThe formulation is commonly used to support fat reduction, appetite suppression, improved insulin sensitivity, and enhanced metabolic efficiency. Retatrutide is researched for its ability to help individuals achieve sustained weight management results while supporting long-term metabolic health and body composition goals.\u003c\/p\u003e\n\u003cp data-start=\"116\" data-end=\"423\"\u003eDelivered in a convenient \u003cstrong data-start=\"812\" data-end=\"850\"\u003e2ml Multi Dose Pen with 200 clicks\u003c\/strong\u003e, Retatrutide provides precise weekly dosing through subcutaneous administration. The progressive dosing structure is designed to support gradual tolerance building and consistent metabolic support throughout the protocol.\u003c\/p\u003e","brand":"Health Tech","offers":[{"title":"Default Title","offer_id":48376694604001,"sku":null,"price":3150.0,"currency_code":"ZAR","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0825\/1935\/9713\/files\/Retatrutide_pepide_pen.png?v=1779006851"},{"product_id":"tirreta-2-4ml-multi-dose-pen-240-clicks","title":"Noventra TirReta – 2.4ml Multi Dose Pen (240 Clicks)","description":"\u003cp\u003eNoventra TirReta is an advanced dual-pathway metabolic peptide blend combining \u003cstrong data-start=\"179\" data-end=\"220\"\u003eTirzepatide 30mg and Retatrutide 30mg\u003c\/strong\u003e in a single formulation. Designed to support aggressive weight management protocols, this hybrid peptide system targets \u003cstrong data-start=\"341\" data-end=\"379\"\u003eGLP-1, GIP, and glucagon receptors\u003c\/strong\u003e to enhance appetite control, metabolic efficiency, and fat utilization.\u003c\/p\u003e\n\u003cp\u003eThe formulation is commonly used to support extreme appetite suppression, improved blood glucose control, enhanced fat oxidation, and preservation of lean muscle during calorie restriction phases. TirReta is designed for individuals seeking advanced body recomposition and high-level metabolic support.\u003c\/p\u003e\n\u003cp\u003eDelivered through a convenient \u003cstrong data-start=\"824\" data-end=\"864\"\u003e2.4ml Multi Dose Pen with 240 clicks\u003c\/strong\u003e, TirReta allows for structured weekly dosing with precise click-based administration. The peptide blend is formulated to provide consistent appetite regulation, metabolic support, and sustained fat-loss assistance throughout progressive protocols.\u003c\/p\u003e","brand":"Health Tech","offers":[{"title":"Default Title","offer_id":48376705876193,"sku":null,"price":2950.0,"currency_code":"ZAR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0825\/1935\/9713\/files\/Noventra_Pharma_Tirreta_multi-dose_peptide_pen.png?v=1779007186"}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0825\/1935\/9713\/collections\/weight.jpg?v=1778034741","url":"https:\/\/health-tech.co.za\/collections\/weight.oembed","provider":"Health Tech","version":"1.0","type":"link"}